Clinical Trial: A Study to Evaluate the Efficacy and Safety of CnU Capsule 750 mg in Patients With Cholesterol Gallstones(GB Stones).

U.S., June 6 -- ClinicalTrials.gov registry received information related to the study (NCT07005752) titled 'A Study to Evaluate the Efficacy and Safety of CnU Capsule 750 mg in Patients With Cholesterol Gallstones(GB Stones).' on May 14.

Brief Summary: The objective of this clinical trial is to evaluate the efficacy and safety of CnU capsule 750 mg administration in patients with Cholesterol gallstone (radiolucent gallstones)

Study Start Date: June, 2025

Study Type: INTERVENTIONAL

Condition: Cholesterol Cholelithiasis

Intervention: DRUG: CnU cap. 250mg & Ursa placebo tab. 200mg

CnU capsule(Magnesium Salt Trihydrate of Chenodeoxycholic Acid and Ursodeoxycholic Acid) and Ursa placebo tablet will be orally administered three times a da...